reported that the endotracheal administration of a single dose (2.5 × 107) of UCMSCs reduced BLM-induced fibrosis by inducing the synthesis of MMP-9 and a decrease in collagen deposition in a rat model of late-stage IPF [95, 113]. This evidence concerns the gene MMP9 and idiopathic pulmonary fibrosis.